Page 21 - Pharma

AIIMS Bhatinda receives Cabinet nod

The new AIIMS, to be built with an investment of Rs 925 crores, will have a hospital with capacity of 750 beds

Sun Pharma signs licensing pact with Spain's Almirall for tildrakizumab in Europe

As per the agreement, which will fetch Sun Pharma $ 50 mn as an initial upfront payment, Almirall will lead the marketing effort of tildrakizumab for treatment of psoriasis in Europe

RPG Life Sciences buys Sun Pharma's 7 brands for Rs 41 crore

Divested products include brands used for treatment of respiratory-track infections, urological disorders, cardiovascular diseases, etc

Core Diagnostics to collaborate with US-based Star Health for oncology test

Through collaboration, the clinical diagnostics firm will launch the Celsee liquid biopsy test for oncology throughout India

Vivimed arm Klar Sehen divests certain products to Ordain Healthcare for Rs 73 cr

The move is part of Vivimed's strategy to exit from the branded formulations in ophthalmology and to focus on CMO and US generic business

European drug regulator suspends medicines tested at Semler Research

European Medicines Agency has cited flaws in bioequivalence studies, which are required for the approval of generics, conducted at the Bangalore-based CRO as the reasons for suspension

US FDA grants approval for Glenmark's skin ointment

The approved product, triamcinolone acetonide ointment (0.5 percent), achieved annual sales of about $ 4.4 million in the US, according to IMS Health

European drug regulator accepts Mylan-Biocon application for biosimilar Pegfilgrastim

The proposed biosimilar Pegfilgrastim, used to treat cancer, is one of the six biologic products co-developed by Mylan and Biocon for the global marketplace

Inclusion of stent in drug price control regime will weaken industry sentiment: FICCI

The move to have an unfavourable impact on the Make in India initiative and FDI inflow in the medical devices sector

GSK to invest $ 360 mn in 3 UK sites to augment pharma production

Investment will be made at Barnard Castle, Montrose and Ware sites for advanced manufacturing of new respiratory and biopharmaceuticals portfolio

China Resources and Macquarie buys stake in Australia's GenesisCare

The consortium bought KKR & Co's 45 percent in GenesisCare, the enterprise value of which is estimated at A$1.7 billion ($1.3 billion)

Leverage on ERP to scale new heights in manufacturing

In today's market scenario, operational difficulties are a cause of concern for manufacturing companies. An efficient ERP system can provide a plethora of benefits, says Atul Pimple

Merck to invest $ 115 mn for expansion of life science campus in Massachusetts

The 280,000-square-foot facility will include a customer collaboration laboratory and training center as well as office space

Collaborate to derive benefits of Skill India initiative

Government, industry, political class at grass route levels, social organisations and beneficiaries need to work together to make a success of the Skill India campaign, says S Narayan

AIIMS Gorakhpur receives Cabinet nod

The project, which is estimated to cost Rs 1011 crore, will be established under Pradhan Mantri Swasthya Suraksha Yojana (PMSSY)

Sun Pharma receives US FDA nod for cholesterol drug rosuvastatin

Rosuvastatin calcium tablets are therapeutic equivalents of IPR Pharmaceuticals Inc's Crestor

US FDA grants approval for Glenmark's rosuvastatin calcium tablet

As per the IMS health sales data for 12 month period ending May 2016, the rosuvastatin calcium tablets market achieved annual sales of approximately $ 6.78 billion

Camlin Fine Sciences receives environmental clearance for Dahej plant

The plant will have capacity to produce 9,000 MTPA and 6,000 MTPA of hydroquinone and catechol, respectively

BD to collaborate with Columbia Asia Hospitals for diabetes management

The company will equip Columbia Asia's team of diabetes management specialists on latest insulin injection technique

Govt plans to table Medical Device Act in Parliament during winter session

PMO held meeting last week with industry association to discuss strategy to promote Make in India initiative in the medical devices sector